GMV
Director Trades
| Date | Director | Value | 
|---|
Company News

Four US university hospitals adopt G Medical’s IDTF platform for remote patient monitoring
An independent diagnostic testing facilities (IDTF) platform developed by medical device and telehealth company G Medical Innovations (ASX: GMV) has been adopted by four US university hospitals for patients requiring cardiac and remote monitoring technologies. Implementation with each hospital is expected to lead to an increase in patient numbers while revenue from new enrolments will […]

G Medical’s heart-monitoring patch authorised for emergency COVID-19 treatment in the US
Medical device and telehealth company G Medical Innovation Holdings (ASX: GMV) has announced approval by the US Food and Drug Administration for its heart-monitoring patch to be used in emergency cases for patients undergoing treatment for COVID-19. The company emerged from a trading halt this morning to report its Vital Signs Monitoring System (VSMS) electrocardiogram […]

G Medical receives TGA approval for device to continuously monitor cardiac patients
Medical device and telehealth company G Medical Innovations (ASX: GMV) has been granted approval by the Therapeutics Goods Administration (TGA) for its extended holter patch for the continuous cardiac monitoring of patients before and after hospital admission. The company said the approval marks a significant milestone as the patch now officially complies with all relevant Australian medical […]

HomeStay Care and G Medical prepare to deliver the next generation of telehealth via television
Aged care specialist HomeStay Care (ASX: HSC) and mobile e-health company G Medical Innovations (ASX: GMV) have unveiled a partnership in which the duo plans to offer the next-generation of care for patients by boosting communication and remote monitoring capability. In a statement to the market this morning, the two companies announced the execution of […]

G Medical receives US over-the-counter authorisation for Prizma smartphone health monitor
Mobile and e-Health company G Medical Innovations Holdings (ASX: GMV) has been granted over-the-counter authorisation for its Prizma medical smartphone case by the US Food and Drug Administration. The authorisation allows the device to be sold in the US as an over the counter item without the need for a prescription and was based on […]

G Medical picks up Taiwan market approval for Prizma device
Mobile and e-health company G Medical Innovations (ASX: GMV) has received regulatory approval in Taiwan for its Prizma device, thereby extending its global market coverage and raising hopes of boosted sales in the near term. Earlier today, G Medical confirmed that Prizma was granted regulatory approval by the Taiwan Food and Drug Administration (FDA) with April […]

Multi-million dollar order secures G Medical’s entry into US commercial market
Mobile and e-health company G Medical Innovations (ASX: GMV) has secured a multi-million dollar purchase order with US healthcare company Hygea Holdings Corp for its medically-certified digital devices. The purchase order covers G Medical’s Prizma medical smartphone case and its Vital Signs monitoring system (or G Medical Patch) over a 24-month term commencing in April […]

G Medical Innovations’ CEO Yacov Geva hands over more cash to fund company’s growth
G Medical Innovations’ (ASX: GMV) chief executive officer and president Yacov Geva has put more of his personal cash into the company, this time in the form of a US$10 million loan facility. Mr Geva initially offered the company a US$3 million loan in May to provide G Medical with extra funding for its growth […]

G Medical Innovations gears up for final commercial approval in China
G Medical Innovations (ASX: GMV) is getting closer to being able to commercialise its Prizma medical smartphone case across China, with CE, CFDA and FDA regulatory audits scheduled at the company’s Guangzhou production facility later this month. The medical device company said the audits are due to commence on 22 September. Following the receipt of […]

G Medical Innovations CEO snaps up 1 million shares on market
G Medical Innovations’ (ASX: GMV) chief executive officer and largest shareholder Yacov Geva has continued to snap up shares in the mobile-device medical technology company. The Cayman Islands-headquartered company today revealed Dr Geva had upped his stake by purchasing 1.036 million fully paid ordinary shares indirectly on 3 April via two separate transactions. A 500,000-share […]
Company Videos
No videos found.